InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Sunday, 02/21/2016 1:26:27 AM

Sunday, February 21, 2016 1:26:27 AM

Post# of 700556
Celldex just posted some interesting news. I've got some studying to do to understand the technology, but it sounds very interesting.

Celldex Presents Preliminary Cohort Data from Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Harvest at the 2016 BMT Tandem Meeting.... Celldex Therapeutics, Inc. (CLDX) today presented new clinical data on CDX-301 (recombinant human Flt3 ligand), a potent hematopoietic cytokine that uniquely expands dendritic cells and hematopoietic stem cells. -- finance.yahoo.com/news/celldex-presents-preliminary-cohort-data-130000531.html



Albeit allogenic DCs, but I'll try to understand if it can have autologous DC amplification application as well.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News